Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/03/2026 | Q4 | $111.2B | -- | -- | $2.63 | -- |
| 10/29/2025 | Q3 | $100.1B | $102.6B | $2.87 | $2.26 | $0.60 |
| 07/23/2025 | Q2 | $94B | $96.5B | $2.31 | $2.20 | $0.11 |
| 04/24/2025 | Q1 | $89.2B | $90B | $2.81 | $2.01 | $0.80 |
| 02/04/2025 | Q4 | $96.7B | $96.4B | $2.15 | $2.13 | $0.02 |
| 10/29/2024 | Q3 | $86.2B | $88.3B | $2.12 | $1.85 | $0.27 |
| 07/23/2024 | Q2 | $84.3B | $84.6B | $1.89 | $1.84 | $0.05 |
| 04/25/2024 | Q1 | $78.7B | $80.5B | $1.89 | $1.51 | $0.38 |
| 01/30/2024 | Q4 | $85.3B | $86.2B | $1.64 | $1.60 | $0.04 |
| 10/24/2023 | Q3 | -- | $76.7B | $1.55 | -- | -- |
| 07/25/2023 | Q2 | -- | $74.6B | $1.44 | -- | -- |
| 04/25/2023 | Q1 | -- | $69.7B | $1.17 | -- | -- |
| 02/02/2023 | Q4 | -- | $75.4B | $1.05 | -- | -- |
| 10/25/2022 | Q3 | -- | $68.5B | $1.06 | -- | -- |
| 07/26/2022 | Q2 | -- | $69.3B | $1.21 | -- | -- |
| 04/26/2022 | Q1 | -- | $67.7B | $1.23 | -- | -- |
| 02/01/2022 | Q4 | -- | $75.1B | $1.53 | -- | -- |
| 10/26/2021 | Q3 | -- | $65.1B | $1.40 | -- | -- |
| 07/27/2021 | Q2 | -- | $61.9B | $1.36 | -- | -- |
| 04/27/2021 | Q1 | -- | $55.4B | $1.31 | -- | -- |
| 02/02/2021 | Q4 | -- | $56.9B | $1.11 | -- | -- |
| 10/29/2020 | Q3 | -- | $46.2B | $0.82 | -- | -- |
| 07/30/2020 | Q2 | -- | $38.1B | $0.51 | -- | -- |
| 04/28/2020 | Q1 | -- | $41.1B | $0.49 | -- | -- |
| 02/03/2020 | Q4 | -- | $46B | $0.77 | -- | -- |
| 10/28/2019 | Q3 | -- | $40.4B | $0.51 | -- | -- |
| 07/25/2019 | Q2 | -- | $38.8B | $0.71 | -- | -- |
| 04/29/2019 | Q1 | -- | $36.2B | $0.47 | -- | -- |
| 02/04/2019 | Q4 | -- | $39.2B | $0.64 | -- | -- |
| 10/25/2018 | Q3 | -- | $33.7B | $0.65 | -- | -- |
| 07/23/2018 | Q2 | -- | $32.8B | $0.23 | -- | -- |
| 04/23/2018 | Q1 | -- | $31.4B | $0.67 | -- | -- |
| 02/01/2018 | Q4 | -- | $32.5B | -$0.22 | -- | -- |
| 10/26/2017 | Q3 | -- | $28B | $0.48 | -- | -- |
| 07/24/2017 | Q2 | -- | $26B | $0.25 | -- | -- |
| 04/27/2017 | Q1 | -- | $24.5B | $0.39 | -- | -- |
| 01/26/2017 | Q4 | -- | $25.9B | $0.38 | -- | -- |
| 10/27/2016 | Q3 | -- | $22.3B | $0.36 | -- | -- |
| 07/28/2016 | Q2 | -- | $21.4B | $0.35 | -- | -- |
| 04/21/2016 | Q1 | -- | $20.1B | $0.30 | -- | -- |
| 02/01/2016 | Q4 | -- | $21B | $0.35 | -- | -- |
Alphabet, Inc. reported $102.6B worth of top line sales in its most recent quarter.
Alphabet, Inc. announced earnings per share of $2.87 which represents a beat of analyst forecast a $2.26 per share.
Alphabet, Inc. reported $61.2B that represents $5.01 per share over the last quarter.
Alphabet, Inc.'s earnings are forecast to grow from $8.04 per share to $7.98 per share next year representing an increase of 31.22%.
Alphabet, Inc.'s next earnings date is February 3, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.